FDA

Scholars assess the state of food-additive regulation.

Researchers address the challenges regulators face in protecting the public amid the rapid growth of neurotechnologies.

Scholars and practitioners debate whether and how to regulate off-label drug use.

Scholar recommends that regulators change food label laws to increase consumers’ access to plant-based meats.

The FTC cracks down on improperly listed drug patents, challenging over 100 patent listings.

Dispensaries could fill the regulatory void for psychedelics and promote public health.

Insurance reimbursement for psychedelic therapy is integral to treatment accessibility.

The convergence of current psychedelics regulatory pathways may bring benefits and new challenges.

Two essays by the student winners of a Penn Carey Law essay competition describe important regulatory issues.

Scholars urge Congress to give FDA more power to regulate dietary supplements.

Scholars analyze FDA’s emergency use authorizations during the COVID-19 pandemic.

Experts recommend measures to improve the regulation of dietary supplements.